Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.560
+0.040 (2.63%)
At close: Dec 16, 2025, 4:00 PM EST
1.530
-0.030 (-1.92%)
After-hours: Dec 16, 2025, 4:05 PM EST
Cibus Market Cap
Cibus has a market cap or net worth of $84.68 million as of December 16, 2025. Its market cap has decreased by -41.07% in one year.
Market Cap
84.68M
Enterprise Value
320.26M
1-Year Change
-41.07%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $84.68M, a decrease of -70.67%. That is a compound annual growth rate of -13.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 84.70M | 3.04% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
| Jul 20, 2017 | 288.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |